Director and CEO, Alkermes plc of Alkermes Plc (30-Year Financial, Insider Trades) Richard F Pops (insider trades) sold 50,000 shares of ALKS on 04/02/2020 at an average price of $13.79 a share. The total sale was $689,500.
Alkermes PLC is a fully integrated, biopharmaceutical company. It applies its scientific expertise and proprietary technologies to research, develop and commercialize pharmaceutical products to address unmet medical needs of patients. Alkermes PLC has a market cap of $2.23 billion; its shares were traded at around $14.12 with and P/S ratio of 1.88. GuruFocus has detected 1 severe warning sign with Alkermes PLC. .
CEO Recent Trades:
- Director and CEO, Alkermes plc Richard F Pops sold 50,000 shares of ALKS stock on 04/02/2020 at the average price of $13.79. The price of the stock has increased by 2.39% since.
- Director and CEO, Alkermes plc Richard F Pops sold 75,000 shares of ALKS stock on 03/26/2020 at the average price of $14.36. The price of the stock has decreased by 1.67% since.
- Director and CEO, Alkermes plc Richard F Pops sold 75,000 shares of ALKS stock on 03/19/2020 at the average price of $14.47. The price of the stock has decreased by 2.42% since.
Directors and Officers Recent Trades:
- SVP, Corp Dev., Alkermes, Inc. Michael J Landine sold 25,000 shares of ALKS stock on 03/24/2020 at the average price of $13.91. The price of the stock has increased by 1.51% since.
- SVP, Corp Dev., Alkermes, Inc. Michael J Landine sold 25,000 shares of ALKS stock on 03/17/2020 at the average price of $13.54. The price of the stock has increased by 4.28% since.
For the complete insider trading history of ALKS, click here
.
